Ascom (ASCN) H2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2024 earnings summary
3 Feb, 2026Executive summary
2024 was marked by significant headwinds, with net revenue down 1.6% at constant currencies and net profit falling to CHF 3.7 million, well below growth ambitions amid macroeconomic volatility.
Regional performance was mixed: strong growth in Nordics and DACH, but underperformance in France and the UK.
Order backlog grew 9% year-over-year to CHF 301.5 million, providing a strong base for 2025.
Despite setbacks, the company maintains a solid balance sheet, positive cash position (CHF 18.6 million), and strong equity ratio (nearly 40%).
Cost measures initiated mid-2024 are expected to show benefits in 2025, with a focus on profitable growth, operational excellence, and innovation.
Financial highlights
Revenue declined by 1.6% at constant currencies and 3.6% at actual currencies year-over-year, with currency headwinds accounting for a 2% negative impact.
EBITDA margin dropped to 7.4% from 10.1% in 2023; net profit was CHF 3.7 million, both substantially lower than initial expectations.
Operating cash flow reached CHF 20 million; CapEx was CHF 15.5 million; dividend paid was CHF 10.8 million.
Order backlog increased to CHF 301.5 million, with about 50% expected to convert to revenue in 2025.
Incoming orders decreased 1.5% at constant currencies.
Outlook and guidance
2025 guidance targets low single-digit revenue growth and an EBITDA margin of 9–10% at constant currencies.
Focus remains on cost base improvement, operational efficiency, and growing recurring revenues.
No midterm guidance due to market volatility; update expected at end of 2025 or early 2026.
Strong order backlog expected to convert to revenue in 2025; cost actions to yield run-rate effects.
Latest events from Ascom
- EBITDA margin rose to 11.7% on higher revenue and profit, with strong 2026 growth outlook.ASCN
H2 20259 Mar 2026 - Revenue down, margin stable, strong backlog; full-year EBITDA margin seen at 9–10%.ASCN
H1 20242 Feb 2026 - EBITDA margin rose to 8.6% as revenue held steady and cash position strengthened.ASCN
H1 202523 Nov 2025 - Interim CEO appointed, new Chairman nominated, and Board to shrink as US/Canada growth prioritized.ASCN
Status Update18 Sep 2025